Meet the FERARO team

Our research team is comprised of world class microbiologists, scientists and researchers.

Dr Simon GoldenbergChief Investigator

Simon Goldenberg MB BS, MSc, FRCPath, MD, DipHIC joined Guy's and St Thomas' NHS Foundation Trust in 2005 and is a consultant microbiologist.

His interests are healthcare associated infections (particularly clostridium difficile infections) and all aspects of infection preventation and control.

He is assistant editor of the Journal of Hospital Infection.

Dr Blair MerrickClinical Research Fellow and Trial Co-ordinator

Blair is a Specialist Registrar in Infectious Diseases and General Internal Medicine at Guy’s and St Thomas’ NHS Foundation Trust. He is currently out of programme running the FERARO trial, which is forming the basis of his studies for a PhD at King’s College, London.

Dr Anna GoodmanCo-investigator

Anna Goodman is a consultant in infectious diseases and general (internal) medicine. She has been a consultant at Guy's and St Thomas' since 2014 and also works at the MRC clinical trials unit at UCL as an associate professor. Anna runs a general infectious diseases clinic on Thursday afternoons. She also supports a dermatology/infectious diseases specialist clinic.

Anna specialises in clinical trials in infectious diseases. She has been the local principal investigator for a number of vaccine trials in malaria and more recently COVID-19.

Dr Jordana BellCo-investigator

ordana Bell leads the epigenomics research group at the Department of Twin Research and Genetic Epidemiology at King's College London. Her research explores the (epi)genomic basis of complex diseases in human populations, focusing on intermediate phenotypes including epigenomic and gut microbiome variation. The broad aim is to apply computational approaches to characterise the biological processes underlying human ageing and age-related cardio-metabolic disease risk, onset, and progression.

Jordana completed her doctoral studies on genetic interactions in human complex traits at the University of Oxford. She was subsequently a Wellcome Trust funded fellow at the Universities of Chicago and Oxford, where her work shifted towards human epigenomics.

Since joining King’s in 2012 Jordana has established a research programme in human population epigenomics and is currently leading research efforts across UK and international collaborative projects, including within DIMENSION, ESSN, GoDMC, and CHARGE consortia. Jordana’s primary research focus is to understand the processes shaping epigenetic variation in human populations, and its biomedical significance. Further projects explore computational approaches for integrative analyses of high-dimensional biomedical data (environmental exposures, DNA sequence, DNA methylation, metabolomics, microbiome, and phenotype) - for prediction of future disease, towards implementing stratified medicine.

Dr Abdel DouiriSenior Trial Statistician

Abdel leads Medical Statistics in the School of Population Health & Environmental Sciences. He is an applied mathematician by background, MSc at Paris-Sorbonne University 1999 and PhD at Paris-Orsay University 2002. He has been involved in a variety of clinical research with world leading research groups in UK and France, and in both academia and industry. His research interests include epidemiology of long-term conditions, predictive medicine and clinical trials design and methodology. Since July 2009, at the School of Population Health & Environmental Sciences he teaches statistics and epidemiology for both undergraduate medical students and postgraduate Masters of Public Health. Abdel is postgraduate module lead of both further epidemiology and statistics for Master of Public Health (MPH) and Public Health Interventions and Evaluation (MSc). He is the director of the statistical consultancy services at KCL and he is also a statistical advisor with the Research Design Service London, Biomedical Research Centre, and King’s College Hospital. He is a Fellow of the Royal Statistical Society and active member with quality improvement section. Abdel is a statistical editor and health economic advisor with Thorax.